5Jannike M. Andersen,Oddvar Myhre,Frode Fonnum.Discussion of the Role of the Extracellular Signal-Regulated Kinase-Phospholipase A2 Pathway in Production of Reactive Oxygen Species in Alzheimer’s Disease[J]Neurochemical Research,2003(2).
6M. A. Pappolla,Y. -J. Chyan,B. Poeggeler,B. Frangione,G. Wilson,J. Ghiso,R. J. Reiter.An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer’s disease[J]Journal of Neural Transmission,2000(2).
7Demopoulos HB,Flamm ES,Seligman ML,et al.Further studies on free-radical pathology in the major central nervous system disorders: effect of very high doses of methylprednisolone on the functional outcome, morphology, and chemistry of experimental spinal cord impact injuryCanadian Journal of Physiology and Pharmacology,1982.
8Yankner B A.Mechanisms of neuronal degeneration in Alzheimer’s diseaseNeuron,1996.
9Ueda K,Shinohara S,Yagami T,et al.Amyloid β-protein potentiates calcium??influx through L-type voltage-senstive calcium channels:A possible involvement of free radicalsJournal of Neurophysiology,1997.
10Smith MA,Harris PL,Sayre LM,et al.Iron accumulation in Alzheimer disease is a source of redox-generated free radicalsProceedings of the National Academy of Sciences of the United States of Amercia,1997.
10Amer can Psychiatric Association. Diagnostic and statistical manual of mental disorders,4th ed (DSM-IV)[M] .Washington DO: American Psychiatric Association, 1994:143.
